BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

679 related articles for article (PubMed ID: 34659246)

  • 1. Comprehensive Analysis of Pyroptosis-Related Genes and Tumor Microenvironment Infiltration Characterization in Breast Cancer.
    Wu J; Zhu Y; Luo M; Li L
    Front Immunol; 2021; 12():748221. PubMed ID: 34659246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of cuproptosis-related genes and tumor microenvironment infiltration characterization in breast cancer.
    Song S; Zhang M; Xie P; Wang S; Wang Y
    Front Immunol; 2022; 13():978909. PubMed ID: 36341328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Landscape of Immune Microenvironment Under Immune Cell Infiltration Pattern in Breast Cancer.
    Xu Q; Chen S; Hu Y; Huang W
    Front Immunol; 2021; 12():711433. PubMed ID: 34512634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular subtypes identified by pyroptosis-related genes are associated with tumor microenvironment cell infiltration in colon cancer.
    Ling Y; Wang Y; Cao C; Feng L; Zhang B; Li S
    Aging (Albany NY); 2022 Nov; 14(22):9020-9036. PubMed ID: 36384889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyroptosis Patterns Characterized by Distinct Tumor Microenvironment Infiltration Landscapes in Gastric Cancer.
    Xiang R; Ge Y; Song W; Ren J; Kong C; Fu T
    Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. m
    Zhang B; Wu Q; Li B; Wang D; Wang L; Zhou YL
    Mol Cancer; 2020 Mar; 19(1):53. PubMed ID: 32164750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyroptosis-related gene mediated modification patterns and immune cell infiltration landscapes in cutaneous melanoma to aid immunotherapy.
    Meng J; Huang X; Qiu Y; Zheng X; Huang J; Wen Z; Yao J
    Aging (Albany NY); 2021 Nov; 13(21):24379-24401. PubMed ID: 34753832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlations between the modification patterns mediated by pyroptosis-related genes, tumor microenvironment, and immunotherapy in soft tissue sarcoma.
    Cai Y; Meng J; Qiu Y; Huang X; Du H; Yao J
    Medicine (Baltimore); 2024 May; 103(20):e38173. PubMed ID: 38758862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and validation of pyroptosis-related gene landscape in prognosis and immunotherapy of ovarian cancer.
    Gao L; Ying F; Cai J; Peng M; Xiao M; Sun S; Zeng Y; Xiong Z; Cai L; Gao R; Wang Z
    J Ovarian Res; 2023 Jan; 16(1):27. PubMed ID: 36707884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyroptosis patterns of colon cancer could aid to estimate prognosis, microenvironment and immunotherapy: evidence from multi-omics analysis.
    Zhou J; Guo H; Liu L; Feng M; Yang X; Hao S
    Aging (Albany NY); 2022 Sep; 14(18):7547-7567. PubMed ID: 36152052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyroptosis-related gene expression patterns and corresponding tumor microenvironment infiltration characterization in ovarian cancer.
    Liu J; Chen C; Geng R; Shao F; Yang S; Zhong Z; Ni S; Bai J
    Comput Struct Biotechnol J; 2022; 20():5440-5452. PubMed ID: 36249562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of pyroptosis related subtypes and tumor microenvironment infiltration characteristics in breast cancer.
    Huang G; Zhou J; Chen J; Liu G
    Sci Rep; 2022 Jun; 12(1):10640. PubMed ID: 35739182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyroptosis-Mediated Molecular Subtypes are Characterized by Distinct Tumor Microenvironment Infiltration Characteristics in Breast Cancer.
    Xu L; Hu Y; Liu W
    J Inflamm Res; 2022; 15():345-362. PubMed ID: 35079221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Turning up the heat on non-immunoreactive tumors: pyroptosis influences the tumor immune microenvironment in bladder cancer.
    Chen X; Chen H; Yao H; Zhao K; Zhang Y; He D; Zhu Y; Cheng Y; Liu R; Xu R; Cao K
    Oncogene; 2021 Nov; 40(45):6381-6393. PubMed ID: 34588621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyroptosis-related prognosis model, immunocyte infiltration characterization, and competing endogenous RNA network of glioblastoma.
    Ding MR; Qu YJ; Peng X; Chen JF; Zhang MX; Zhang T; Hu B; An HM
    BMC Cancer; 2022 Jun; 22(1):611. PubMed ID: 35658846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of lung squamous cell carcinoma immune microenvironment and immunotherapy efficiency with pyroptosis-derived genes.
    Deng X; Wang Z; Luo Y; Li Z; Chen L
    Medicine (Baltimore); 2022 Sep; 101(37):e30304. PubMed ID: 36123889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular subtyping and immune score system by a novel pyroptosis-based gene signature precisely predict immune infiltrating, survival and response to immune-checkpoint blockade in breast cancer.
    Zeng X; Huang X; Yin L; Yu H; Wang S; Li L
    Cancer Genet; 2023 Aug; 276-277():60-69. PubMed ID: 37506530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive characterization of pyroptosis phenotypes with distinct tumor immune profiles in gastric cancer to aid immunotherapy.
    Huang K; Lin Y; Qiu G; Wang S; Feng L; Zheng Z; Gao Y; Fan X; Zheng W; Zhuang J; Luo F; Feng S
    Aging (Albany NY); 2023 Aug; 15(16):8113-8136. PubMed ID: 37595258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of cuproptosis-related patterns and construction of a scoring system for predicting prognosis, tumor microenvironment-infiltration characteristics, and immunotherapy efficacy in breast cancer.
    Li W; Zhang X; Chen Y; Pang D
    Front Oncol; 2022; 12():966511. PubMed ID: 36212436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of pyroptosis regulation patterns and their influence on tumor immune microenvironment and patient prognosis in glioma.
    Fan T; Wan Y; Niu D; Wang B; Zhang B; Zhang Z; Zhang Y; Gong Z; Zhang L
    Discov Oncol; 2022 Mar; 13(1):13. PubMed ID: 35274175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.